(Q44481687)

3 December 2017

title

Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance (English)

1 reference

3 December 2017

1 reference

1 reference

Fu L

1

1 reference

3 December 2017

Cheng YC

series ordinal

2

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

3 December 2017

published in

Biochemical Pharmacology

1 reference

3 December 2017

volume

55

1 reference

3 December 2017

issue

10

1 reference

3 December 2017

page(s)

1567-1572

1 reference

Hepatitis B virus-induced hepatocellular carcinoma: possible roles for HBx.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

A preliminary trial of lamivudine for chronic hepatitis B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Lamivudine resistance inimmunocompetent chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Identification of four conserved motifs among the RNA-dependent polymerase encoding elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

HIV resistance to reverse transcriptase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Secreted placental alkaline phosphatase as a eukaryotic reporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900050-1

10.1016/S0006-2952(98)00050-1

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference